A qualitative study of women's views on overdiagnosis and screening for thyroid cancer in Korea

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Park, Sang Hee ^a   Lee, Bomyee ^b   Lee, Sangeun ^b   Choi, Eunji ^b   Choi, Eun Bi ^b   Yoo, Jisu ^b   Jun, Jae Kwan ^b   Choi, Kui Son ^b  

^a Sogang University   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Overdiagnosis; Qualitative; Screening; Thyroid cancer

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO ILLNESS; AWARENESS; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ERROR; DOCTOR PATIENT RELATION; EXPLORATORY RESEARCH; FEMALE; HEALTH EDUCATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL CARE; MEDICAL HISTORY; MIDDLE AGED; QUALITATIVE RESEARCH; RISK ASSESSMENT; SOUTH KOREA; SOUTH KOREAN; THYROID CANCER; ATTITUDE TO HEALTH; EARLY CANCER DIAGNOSIS; HEALTH SERVICE; MASS SCREENING; PROCEDURES; PUBLIC OPINION; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; THYROID NEOPLASMS;

ADULT; AGED; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MASS SCREENING; MEDICAL OVERUSE; MIDDLE AGED; PUBLIC OPINION; QUALITATIVE RESEARCH; REPUBLIC OF KOREA; RISK FACTORS; SEX FACTORS; THYROID NEOPLASMS;

EID: 84946405423     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1877-6     Document Type: Article

References (17)

1. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014;46(2):109-23.
2. Cho BY, Choi HS, Park YJ, Lim JA, Ahn HY, Lee EK, et al. Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid. 2013;23(7):797-804.
3. GLOBOCAN 2012. estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr. Accessed 6 Feb 2015.
4. The Korea Central Cancer Regsitry. The national cancer center. Annual report of cancer statistics in Korea in 2011. Seoul: Ministry of Health and Welfare; 2013.
5. Oh C-M, Jung K-W, Won Y-J, Shin A, Kong H-J, Lee J-S. Age-Period-Cohort Analysis of Thyroid Cancer Incidence in Korea. Cancer Res Treat. 2014; doi:10.4143/crt.2014.110.
6. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med. 2014;371(19):1765-7.
7. Lee JH, Shin SW. Overdiagnosis and screening for thyroid cancer in Korea. Lancet. 2014;384(9957):1848.
8. Bann DV, Goyal N, Camacho F, Goldenberg D. Increasing incidence of thyroid cancer in the commonwealth of Pennsylvania. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1149-56.
9. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-13.
10. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, et al. Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013;346:f158.
11. Waller J, Douglas E, Whitaker KL, Wardle J. Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ open. 2013;3(4):e002703.
12. Barbour R, Kitzinger J. Developing focus group research: politics, theory and practice. London: SAGE Publication Ltd.; 1999.
13. Morgan DL. Successful focus groups: Advancing the state of the Art. Newbury Park: SAGE Focus Edition; 1993.
14. Esserman LJ, Thompson Jr IM, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013;310(8):797-8.
15. Junod B, Zahl PH, Kaplan RM, Olsen J, Greenland S. An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts. BMC Cancer. 2011;11:401.
16. Jorgensen KJ, Gotzsche PC. Content of invitations for publicly funded screening mammography. BMJ. 2006;332(7540):538-41.
17. Schwartz LM, Woloshin S, Fowler Jr FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291(1):71-8.